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Systemic Lupus Erythematous (SLE) is one of the major autoimmune diseases that can cause 
severe damage to the tissues and organs in the bodyan  lead to high mortality rates. The 
clinical manifestations are characterized by the production of autoantibody immunoglobulin 
G (Ig G) that fights component of the nucleus. The present scientific information issues about 
peculiar property of Tridax procumbens as immunosuppressant by inhibiting enzyme of 
cyclooxygenase-2 (COX-2) on surface of B cells. This study approved effect of the extract of 
Tridax procumbens on human lymphocytes cells line with SLE disease.  The aim of this study 
was to approve effect of extract of Tridax procumbens in suppressing Ig G concentration from 
patient with stable SLE and patient with active SLE in vitro.  This study was an in vitro 
experimental design on lymphocytes cell line that ws isolated from whole blood patient with 
stable SLE and active SLE. Lymphocyte cells from healthy volunteer were also collected as 
control. American Rheumatism Association Diagnostic was used for inclusion criteria.Tridax 
procumbens was extracted with maceration method in solution of ethyl acetate. The extract 
was divided in several doses as  immunosuppressant i.e.1000; 250; 62.5; 31.25; 15.13; and 
3.91 µg/mL. Supernatant of the cultured cells was colle ted and examined for measuring Ig G 
concentration as secretion from activated B cells by ELISA. Ethical clearance had been 
completed before this study started.  The extract of Tridax procumbens significantly 
suppressed Ig G secretion in patient with stable SLE at dose over 62.5 µg/mL, but Ig G 
concentration in patient with active SLE was significantly increased when compared with 
control. Furthermore from the analysis, effect of the Tridax procumbens extract on Ig G 
concentration followed dose dependent response.  In in-vitro study, the extract of Tridax 
procumbens could significantly suppress Ig G secretion in healthy volunteer and patient with 
stable SLE. Otherwise, the extract does not suggest for patient with active SLE and it needs 
caution in use and investigation in-depth. 
 




Penyakit Systemic Lupus Erythematous (SLE) merupakan salah satu penyakit autoimun yang 
sering menyebabkan kerusakan jaringan dan organ sehingga angka kematiannya tinggi. 
Karakteristik patognomonik penyakit SLE ditandai ada produksi auto antibody 
immunoglobulin G (Ig G) yang melawan komponen nukleosom tubuh sendiri. Penelitian 
ilmiah terbaru menunjukkan bahwa ekstrak Tridax procumbens memiliki efek imunosupresan 
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melalui hambatan enzim cyclooxygenase-2 (COX-2) pada permukaan sel B. Pada studi ini 
menguji efek ekstrak Tridax procumbens pada cells line limfosit dari pasien SLE.  Tujuan 
penelitian ini adalah mengetahui efek ekstrak Tridax procumbens dalam menekan konsentrasi 
Ig G pasien dengan SLE stabil dan pasien dengan SLE aktif secara in vitro. Penelitian ini 
merupakan penelitian eksperimen pada cell line limfosit yang diisolasi dari whole blood pasien 
dengan SLE stabil dan SLE aktif. Kelompok kontrol limfosit diambil dari sukarelawan sehat. 
Kriteria inklusi pasien yang mengikuti penelitian ini berdasarkan kriteria diagnostik American 
Rheumatism Association.  Tridax procumbens diekstraksi dengan metode maserasi larutan etil 
asetat. Ekstrak dibagi menjadi beberapa dosis sebagai imunosupresan yaitu 1000; 250; 62,5; 
31,25; 15,13; dan 3,91 µg/mL. Supernatan dari sel kultur dikoleksi dan diukur onsentrasi Ig 
G yang merupakan sekresi sel B dengan menggunakan metode ELISA. Persetujuan etik 
dilakukan sebelum penelitian dilakukan. Ekstrak Tridax procumbens menekan sekresi Ig G 
pasien dengan SLE stabil pada dosis diatas 62,5 µg/mL, namun konsentrasi Ig G dari pasien 
dengan SLE aktif meningkat secara signifikan dibandingkan dengan kontrol. Efek ekstrak 
Tridax procumbens pada konsentrasi Ig G mengikuti dose dependent response.  Pada 
penelitian ini, ekstrak Tridax procumbens dapat menekan sekresi Ig G dari pasien dengan SLE 
stabil dan sukarelawan sehat. Pemberian ekstrak T idax procumbens tidak dianjurkan pada 
pasien dengan SLE aktif, namun hal ini masih membutuhkan penelitian lebih mendalam. 
 




Systemic lupus is disease involving multi 
system disorder in women and men at a 
young age (1). It is a complex disease that 
has characteristics such hyperactivity of 
immune system and built up damage to the 
blood vessels (2). Consequently, the 
manifestation is in many organs throughout 
the body (3). The actual incidence of the 
disease system iclupusis very difficult to 
estimate, because of the complexity of the 
disease and the difficulty of diagnosis. In 
the United State, a developed country 
occurred more than 16,000 new cases a 
year. According to the survey, more people 
suffered from lupus than AIDS, cerebral 
palsy, and multiple sclerosis (4). 
 
The main cause of this disease has still 
unknown certainly. The incidence of this 
disease showed that case of SLE reached 
25-50% in identical twins and 5% in 
dizygotic twins. This suggested that genetic 
factors had played an important role as a 
factor in disease predisposition. However, 
almost all cases were sporadic and a rise 
non genetic that could be identified, so 
environmental factors were also known to 
have an essential role in the onset of the 
disease (5). The pathognomonic sign of 
lupus is found of auto antibodies that 
formed to fight the nuclear component. 
Auto antibodies are directly involved in the 
activation of complement and immune 
complex formation. Thus, this 
inflammatory response affects in many 
tissues and more common such the skin 
and kidneys (6). 
 
Tridax procumbens, in Indonesia, known 
herbs Songgolangit, widely used as 
ingredients (7). In traditional medicine, the 
leaves of this plant were used all parts of 
the plant to treat some infections such 
bronchitis and diarrhea (8). 
Pharmacological studies indicated that the 
herb had anti-inflammatory effects, 
hepatoprotector, anti-leishmania, anti-
hyperglycemic, and hair grower. From the 
research phytochemicals, the herbs were 
isolated constituents of lipids, sterols, 
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flavonoids, polysaccharides and derivate 
bergenin. The leaf juice of Tridax 
procumbens has affect for healing open 
wounds due to greater anti-inflammatory 
effect (9). Tridax procumbens resembled 
steroid effect on minimizing wound 
contraction and granulation (10). Anti-
inflammatory effects of Tridax procumbens 
obtained through inhibition 
ofcyclooxygenase-2 (COX-2) enzyme (6). 
This enzyme had important component in 
class switching of Ig G on surface of 
lymphocytes B. By inhibiting of this 
pathway, it leaded to suppress autoantibody 
Ig G concentration (11). The recent study 
has also developed monoclonal antibody 
that has target at B cells (12). 
 
This study was expected to explore Tridax 
procumbens that had immunosuppressant 
effects by inhibition of COX-2 enzyme in 
the cell surface of B lymphocytes. As a 
result, secretion of immunoglobulin G was 
suppressed directly as an essential role in 




This study is an experimental research 
laboratory with ethical clearance in 
humans. The research analyzed Tridax 
procumbens extract on cultured 
lymphocytes. In this study, lymphocytes 
were taken from whole blood two lupus 
patients; one was from patient with stable 
lupus, another was sample from patient 
with exacerbated lupus. Normal 
lymphocyte cells were taken from whole 
blood a healthy volunteer as control. 
Patients diagnosed with SLE based on 
ARA criteria by physician at department of 
internal medicine, Hospital of Sardjito, 
Yogyakarta. In addition, inclusion criteria 
included female with age of 20 to 50 years 
old, and not being consumption any 
immunomodulatory agents for 7 days prior 
blood sample taken. Patient with 
concomitants disease and being either 
pregnant or breast feeding was excluded in 
this study. 
 
Tridax procumbens was extracted with 
maceration method in solution of ethyl 
acetate. Concentrations of the extract were 
1000; 250; 62.5; 15.125, and 3.91 µg/mL. 
As positive control, prednisone was used 
for standard treatment in SLE as 
immunosuppressant and aspirin was used 
for COX-2 enzyme inhibitor. Either 
prednisone or aspirin was prepared in 
concentration of 250; 62.5; 15.125, and 
3.91 µg/mL. All of concentrations were 
replicated in triplet. 
 
Lymphocytes were isolated from whole 
blood samples of lupus patients as treatmet 
cells and a healthy volunteer as control 
cells. Whole blood was washed with10% 
PBS twice and centrifuged by 1600 rpm for 
10 minutes. Supernatant was discarded 
before the bottom layer was put with 
Isopaque-ficoll in density of 0.074 
approximately 6 mL in tubes. Then the 
whole blood is put through the wall of the 
tube carefully. Furthermore, it was 
centrifuged at speed of 1600 rpm for 10 
minutes. Finally, buffycoat isolated and 
washed with PBS (13). 
 
Lymphocyte cells were growth in RPMI 
1640, cell cultured media, with 10% FBS 
for 3 days in 96 wells in 3 groups, one 
group was lymphocytes from patient with 
stable lupus, one group was lymphocytes 
from patient with exacerbated or active 
lupus, and another was from healthy 
volunteer. Each group had 6 wells for the 
extract, 5 wells for prednisone treatment, 
and 5 wells for aspirin treatment. All of 
concentrations were replicated in triplet. 
Supernatant was taken to measure the 
concentration of Ig G by using the human-
immunoglobulin G ELISA procedures 
(11). 
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Analysis is based on comparison between 
the concentration of immunoglobulin G in 
the extract and in control group. The 
average concentration of Ig G within the 
extract group was compared statistically to 
prednisone and aspirin group. The results 
of the analysis revealed significant based 
on the value of statistical significance (p) 
by using a statistical test. Differences were 
considered significant if p-value was less 
than 0.05. 
 
RESULTS AND DISCUSSIONS 
 
Tridax procumbens was isolated from 
Health Office UPT Materia Medica, 
Malang,  East Java. Tridax procumbens 
was extracted with maceration method 
since the materials were unstable in heated 
environment. The extraction process used 
semi-polar solvent of ethyl acetate, thus it 
was also expected to extract components of 
polar primarily inside endosel. 
 
Effect of Tridax procumbens on Ig G 
concentration 
 
The results of the calculation Ig G 
concentration in supernatants of culture of 
lymphocytes that had been given the 
extract of ethyl acetate extract for 3 days 
can be seen in Table1. Untreated group as 
negative control was performed on cultured 
lymphocytes within each test group (the 
healthy, stable SLE and active SLE 
patients). Basically, start level of Ig G 
concentrations each group were difference, 
the highest level was from cultured 
lymphocytes of patient with active SLE. 
There was a significant decrease in the 
levels of immunoglobulin G in cultured 
lymphocytes of either healthy volunteer or 
patient with stable SLE in the 
concentration of the extract above 62.5 
µg/mL. On the other hand, the opposite 
occurred in patient with active SLE, the 
concentration of immunoglobulin G 
increased significantly from the lowest 
dose to the highest dose of the extract. This 
suggested that the ethyl acetate extract of 
Tridax procumbens not recommended for 
people with SLE who has experienced an 
attack of lupus but this needs further study. 
 
In this study, positive control was given the 
immunosuppressant prednisone as the 
treatment of SLE. The concentration of the 
test immunosuppressant prednisone only 
mphocyte cell lines was 250; 62.5; 15.125, 
and 3.91 µg/mL. The results of the 
calculation of the concentration of Ig G in 
supernatants of lymphocytes cultured cells 
that have been given prednisone for 3 days 
can be seen in Table 2. Prednisone, 
acortico steroid drug, had a mechanism by 
inhibiting the expression of the role of 
phospholipase A on the cell membrane that 
could lead to suppression of excretion of Ig 
G (11)(14). In the statistical results 
indicated there was a decrease in the 
concentration of Ig G from healthy 
volunteer, patients with stable SLE, and in 
patients with active SLE. Overall, in Table 
2 also showed that the decrease in the 
concentration of Ig G occurred in lowest to 
highest concentration of prednisone. 
 
The use of aspirin for this study as a 
positive control based on previous studies 
related to that the ethyl acetate extract of 
Tridax procumbens had effect on 
suppression of Ig G secretion by inhibition 
of COX pathway (11).  
 
The concentration of aspirin only 
mphocytes cultured cells was 250; 62.5; 
15.125, and 3.90625 µg/mL. The results of 
the calculation of the concentration of 
immunoglobulin G in supernatants of 
lymphocytes cultured cells that have been 
given aspirin for 3 days can be seen in 
table 2.  
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Tabel 1. Concentrations of Ig G in cultured lymphocytes that had given extract of Tridax 
procumbens. 




Concentration of Ig G  (ng/mL) 
(mean+ SD) 
p value 
Healthy volunteer 1000 660.38+ 4.50 0.001 
250 696.38+ 27.47 0.014 
62.50 701.17+  4.78 0.023 
15.13 714.32+  0.00 0.106 
3.91 721.00+  4.57 0.231 
0 736.56+  0.36 - 
Patient with stable 
SLE 
1000 632.99+  0.93 <0.001 
250 634.82+ 27.82 <0.001 
62.50 696.42+ 29.50 0.001 
15.13 785.72+ 11.86 0.132 
3.91 808.64+ 8.67 0.685 
0 816.18+ 4.37 - 
Patient with active 
SLE 
1000 1113.14+6.51 <0.001 
250 928.69+0.91 <0.001 
62.50 926.14+0.90 <0.001 
15.13 910.01+1.33 0.001 
3.91 909.07+1.77 0.001 
0 890.48+2.60 - 
p value was adjusted based on baseline level the concentration of Ig G without treatment 
 
Tabel 2. Concentrations of Ig G in cultured lymphocytes had been given the extract of Tridax 
procumbens, prednison and aspirin 




Ig G (ng/mL) p 
value 
Ig G (ng/mL) p 
value The extract 
(mean + SD) 
Prednison 
(mean + SD) 
Aspirin 
(mean + SD) 
Healthy volunteer 250 696.38+27.47 613.47+ 5.38  614.94+ 2.10  
62.50 701.17+  4.78 621.11+ 2.42  621.11+ 2.42  
 15.13 714.32+  0.00 667.69+ 0.65  651.79+ 0.00  
 0 736.56+  0.36 736.56+ 0.36  736.56+ 0.36  
    0.128  0.106 
Patient with stable 
SLE 
250 634.82+27.82 615.57+ 0.60  631.69+ 4.00  
62.50 696.42+29.50 683.75+ 0.99  691.81+ 0.34  
 15.13 785.72+11.86 697.55+ 1.70  743.95+ 0.73  
 3.91 808.64+ 8.67 727.48+ 1.77  768.96+ 2.99  
 0 816.18+  4.37 816.18+ 4.37  816.18+ 4.37  
    0.323  0.718 
Patient with active 
SLE 
250 928.69+  0.91 673.01+ 0.63  667.01+ 0.33  
62.50 926.14+  0.90 667.01+ 0.33  692.52+ 1.35  
15.12 910.01+  1.33 673.01+ 2.29  707.71+ 0.35  
3.91 909.07+  1.77 704.55+ 2.06  747.81+ 3.28  
0 890.48+  2.60 890.48+ 2.60  890.48+ 2.60  
   0.002  0.003 
p value was adjusted based on the concentration of Ig G in cultured lymphocytes with the 
extract treatment  
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In the statistical results indicated that a 
decrease in the concentration of Ig G from 
healthy volunteer, patient with stable SLE, 
and in patients with active SLE. In Table 2 
also showed that the decrease in the 
concentration of immunoglobulin G 
occurred significantly from lowest to 
highest concentration of aspirin. This 
suggested that suppression of 
immunoglobulin G concentrations in 
lymphocytes cultured cells through 
inhibition of the enzymecyclooxigenase. 
 
Effect ofcyclooxygenase 2 (COX-2) 
inhibitor of the extract on B cell function, 
assessed as Ig G autoantibody production. 
Based on our studies on lupus lymphocytes 
in vitro from humans, we designed the 
present study to test the effects of 
suppression Ig G secretion by aspirin as 
cyclooxygenase inhibitor and prednisone as 
immunosuppressive agent. Surprisingly, 
the low dose and high dose of aspirin and 
prednisone were effective in suppressing 
secretion of Ig G from lymphocytes of 
patient with active SLE, stable SLE, and 
healthy volunteer. Prednisone was the most 
potent in suppressing Ig G (15). Moreover, 
therapy with the COX-2 inhibitors, aspirin, 
in the short term, even at the lowest doses, 
could also suppress the functions of B cells 
reducing Ig G auto antibody production in 
response to the major lupus auto antigen, 
nucleosome (16)(17). 
 
Baseline levels of Ig G autoantibodies 
produced by lymphocytes culture, were as 
follows: for either healthy volunteer or 
patient with stable SLE in the 
concentration of the extract above 62.5 
µg/mL were significance decrease but not 
for patient with active SLE, it was 
significance increase between the lowest 
dose and the highest dose. Lymphocytes 
from active SLE actually hyper expressed 
COX-2 for B cells activation which could 
have been inhibited by prednisone and 
aspirin. The hyperactive B cells of lupus 
not only produce Ig G auto antibodies, but 
also co stimulate and present auto antigens 
to pathogenic T cells in lymphocytes cells 
line, and may stimulate themselves by 
increasing activity of COX-2 (18). In 
relation to human lupus, this study shows 
the importance of COX-2 as a target for 
stable lupus therapy, using aspirin, 
prednisone, and the extract of Tridax 
procumbens. It would be interesting to 
explore whether Tridax procumbens has 
difference pathway to suppress 
autoantibody in active SLE. Eventhough, 
based on this study, the extract ofethyl 
acetate from Tridax procumbens is not 
recommended for patients with active SLE. 
This can be caused by an autoimmune 
nature of B lymphocyte cells are 





The extract of Tridax procumbens had 
immunosuppressive effects in reducing the 
concentration of immunoglobulin G 
significantly in cultured lymphocytes of 
SLE patients with stable and healthy 
individual with concentrations of the 
extract above 62.5 µg/mL. 
 
The extract of Tridax procumbens 
increased the concentration of  





The extract of Tridax procumbens needs to 
explore in-depth to suppress secretion of 
immunoglobulin G in either difference 
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autoimmune diseases or difference 
pathway trasduction. 
 
This study needs further research to 
determine the components contained in the 
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